| |
|
|
|
Leap Therapeutics Inc  
|
|
2.64 0.03 (0.01%) |
02-24 16:00 |
|
Open: |
2.67 |
Pre close: |
2.61 |
Target:
|
3.32
|
|
High: |
2.7478 |
Low: |
2.6101 |
Resistance:
|
2.84
3.24
|
|
Volume: |
266,690 |
Market Cap: |
157M |
Support:
|
2.19
1.82
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.73
 |
MACD |
MACD(12,26):
|
0.12 |
|
MA(20): |
2.62  |
Signal(12,26,9): |
0.14 |
|
MA(100): |
2.11 |
Stochastic Oscillator |
%K(14,3):
|
40.94 |
|
MA(250): |
2.05 |
%D(3): |
50.19 |
|
Average Volume(K) |
3-Month: |
103782
|
52-Week |
High:
|
3.24 |
|
10-Days: |
118551 |
Low: |
1.15 |
|
RSI |
RSI(14):
|
52.11 |
Change(%): |
0.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.842 |
Return on Equity (ttm) |
-98.1 |
Shares Out. (M) |
59.66 |
|
EPS Est. Current Year |
-3.160 |
Return on Assets (ttm) |
-49.1 |
Shares Float (M) |
37.28 |
|
EPS Est. Next Year |
-3.090 |
PEG Ratio |
0.00 |
% Held by Insiders |
12.04 |
|
EPS Est. Next Quarter |
-0.630 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
59.01 |
|
Forward EPS |
-1.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1220 |
|
Book Value (p.s.) |
0.890 |
EBITDA (p.s.) |
-0.491 |
P/E |
-3.14 |
|
Sales Per Share |
0.019 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.97 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-25.86 |
P/S |
140.63 |
|
Operating Margin |
-2605.42 |
Levered Free Cash Flow
(M) |
-16.06 |
P/CF |
-6.09 |
|
|
|
|
|
|
